Moderna sues Pfizer, BioNTech over COVID-19 vaccine patents

United States News News

Moderna sues Pfizer, BioNTech over COVID-19 vaccine patents
United States Latest News,United States Headlines
  • 📰 AKNewsNow
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 53%

Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, Spikevax.

Pfizer spokeswoman Pam Eisele said the company had not fully reviewed Moderna’s lawsuit, but the drugmaker was surprised by it, given that their vaccine is based on proprietary technology developed by both BioNTech and Pfizer.

“When COVID-19 emerged, neither Pfizer nor BioNTech had Moderna’s level of experience with developing mRNA vaccines for coronaviruses,” Moderna said in a complaint filed Friday in the U.S. District Court for the District of Massachusetts. Moderna CEO Stephane Bancel said in a prepared statement that the vaccine developer pioneered that technology and invested billions of dollars in creating it.

Moderna said in its complaint that Pfizer and BioNTech copied some critical features of its technology, including making the “exact same chemical modification to their mRNA that Moderna scientists first developed years earlier” and went on to use in Spikevax.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

AKNewsNow /  🏆 460. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna suing Pfizer over vaccine technologyModerna suing Pfizer over vaccine technologyModerna said it’s suing Pfizer and BioNTech over alleged patent infringements, the company announced Friday.
Read more »

Moderna files patent infringement lawsuits against Pfizer and BioNTech over mRNA Covid-19 vaccinesModerna files patent infringement lawsuits against Pfizer and BioNTech over mRNA Covid-19 vaccinesModerna on Friday filed patent infringement lawsuits against Pfizer and BioNTech 'for infringing patents central to (its) mRNA technology platform,' the company said in a news release Friday.
Read more »

Modern Sues Pfizer, BioNTech for Patent Infringement Over mRNA Tech Used to Develop COVID VaccineModern Sues Pfizer, BioNTech for Patent Infringement Over mRNA Tech Used to Develop COVID VaccineModerna announced Friday it is suing Pfizer and its German partner BioNTech, alleging the two companies copied Moderna’s technology in its development of their COVID-19 vaccine Comirnaty. Modern said in a news release that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 covering its mRNA technology, which Moderna used to develop its own COVID-19 vaccine, Spikevax. “We…
Read more »

Moderna Sues Pfizer, BioNTech for Patent Infringement Over mRNA Tech Used to Develop COVID VaccineModerna Sues Pfizer, BioNTech for Patent Infringement Over mRNA Tech Used to Develop COVID VaccineModerna announced Friday it is suing Pfizer and its German partner BioNTech, alleging the two companies copied Moderna’s technology in its development of their COVID-19 vaccine Comirnaty. Moderna said in a news release that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 covering its mRNA technology, which Moderna used to develop its own COVID-19 vaccine, Spikevax. “We…
Read more »

The Panthers and the Eagles - Friday Football FeverThe Panthers and the Eagles - Friday Football FeverNate Griffin and Shelby Rose join the Eagle at Second Baptist High School and the Panthers at St. Pius X for an early morning pep rally before the Friday night lights hit the field.
Read more »

Why Fed's Powell speech on Friday likely matters less for stocks than a sputtering housing marketWhy Fed's Powell speech on Friday likely matters less for stocks than a sputtering housing marketInflation, job losses and the cooling housing market are top factors that could drive a U.S. recession, according to Charles Schwab's Kevin Gordon.
Read more »



Render Time: 2025-02-22 08:22:20